Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.66B.
ENTERPRISE VALUE (EV)
$1.66B
Generate Biomedicines, Inc.
Market Cap
$1.79B
Enterprise Value (EV)
$1.66B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.79B | $1.66B |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | $1.98B |
| Novocure Ltd (NVCR)vs › | $1.83B | $1.97B |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | $1.70B |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | $2.42B |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.73B | $1.37B |
| Absci Corporation (ABSI)vs › | $1.84B | $1.74B |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | $3.79B |
| Personalis, Inc. (PSNL)vs › | $1.71B | $1.66B |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.86B | $1.68B |
Market Cap
$1.79B
Total Debt
$0.00
Cash
$121.65M
Enterprise Value
$1.66B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
